Ascendis Pharma ADR (ASND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ASND | RGEN | LEGN | ||
| Company | Ascendis Pharma ADR | Repligen Corp | Legend Biotech Corp ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 123.45 | 139.61 | 40.18 | ||
| High | 124.63 | 142.11 | 40.73 | ||
| Low | 122.43 | 136.54 | 39.09 | ||
| Last | 122.64 | 141.76 | 39.75 | ||
| Change | -1.74 | +2.86 | -0.39 | ||
| % Change | -1.40% | +2.06% | -0.97% | ||
| Volume | 282,500 | 660,000 | 1,760,900 | ||
| 20-Day Average Volume | 472,205 | 706,255 | 1,626,540 | ||
| Previous Close | 124.38 | 138.90 | 40.14 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 125.90 | 138.55 | 41.66 | ||
| 20-Day Raw Stochastic | 28.83% | 61.41% | 26.03% | ||
| 20-Day Relative Strength | 42.97% | 51.22% | 39.80% | ||
| Weighted Alpha | +6.29 | -15.14 | -37.64 | ||
| Today's Opinion | 72% Sell | 72% Sell | 100% Sell | ||
| Previous Opinion | 100% Sell | 88% Sell | 100% Sell | ||
| Last Month's Opinion | 56% Sell | 64% Sell | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.32% since 11/14/24 | -0.47% since 11/14/24 | -0.35% since 11/14/24 | ||
| Low | 118.05 on 11/15/24 | 121.52 on 11/15/24 | 36.92 on 11/19/24 | ||
| High | 133.00 on 11/15/24 | 142.11 on 11/21/24 | 41.00 on 11/20/24 | ||
| 1-Month | |||||
| %Chg | -4.68% since 10/21/24 | -4.99% since 10/21/24 | -8.52% since 10/21/24 | ||
| Low | 118.05 on 11/15/24 | 121.52 on 11/15/24 | 36.92 on 11/19/24 | ||
| High | 133.97 on 10/28/24 | 154.48 on 11/12/24 | 47.79 on 11/05/24 | ||
| 3-Month | |||||
| %Chg | -10.48% since 08/21/24 | -7.32% since 08/21/24 | -29.60% since 08/21/24 | ||
| Low | 111.09 on 09/12/24 | 121.52 on 11/15/24 | 36.92 on 11/19/24 | ||
| High | 155.53 on 09/20/24 | 154.48 on 11/12/24 | 59.62 on 09/03/24 | ||
| 6-Month | |||||
| %Chg | -0.17% since 05/21/24 | -15.06% since 05/21/24 | -7.47% since 05/21/24 | ||
| Low | 111.09 on 09/12/24 | 113.50 on 06/20/24 | 36.92 on 11/19/24 | ||
| High | 155.53 on 09/20/24 | 172.65 on 08/01/24 | 60.87 on 07/25/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 7,542,651 | 7,782,150 | 7,317,723 | ||
| Shares Outstanding, K | 60,642 | 56,027 | 182,305 | ||
| Annual Sales | 288,670,000 | 638,760,000 | 285,140,000 | ||
| Annual Net Income | -521,070,000 | 41,580,000 | -518,250,000 | ||
| Last Quarter Sales | 63,590,000 | 154,870,000 | 160,210,000 | ||
| Last Quarter Net Income | -109,080,000 | -650,000 | -125,320,000 | ||
| 60-Month Beta | 0.66 | 0.96 | 0.11 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.89 on 11/14/24 | 0.43 on 11/12/24 | -0.34 on 11/12/24 | ||
| Latest Earnings Date | 11/14/24 | 11/12/24 | 11/12/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 93.79 | 0.00 | ||